Articles mentioning Pfizer, Inc. (PFE)

Results 11 - 20 of 4004 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for PFE

Investing | February 03, 2012

Curing Diseases Makes For a Bad Business Model

Vertex got to a lot of patients quickly, but now what?

High-Growth Investing | February 03, 2012

This Just In: Upgrades and Downgrades

Bank of America relents on Dendreon.

High-Growth Investing | February 03, 2012

Has Elan Become the Perfect Stock?

Finding companies that have all the right stuff can produce winners.

Investing | February 02, 2012

The Dow's Biggest Losers

The Dow stocks that fell the most today.

High-Growth Investing | February 02, 2012

The Disadvantage of a Successful Pipeline

Biogen ramps up R&D spending.

High-Growth Investing | January 31, 2012

This Drug Approval Is Good For the Industry

Dividends & Income Investing | January 31, 2012

Lipitor Loss? What's That?

Pfizer loses Lipitor exclusivity and still beats analysts.

Investing | January 31, 2012

Why the Dow Moved Today

Breaking down the market.

Dividends & Income Investing | January 31, 2012

Kidney Cancer? There's a Drug for That

Investing | January 31, 2012

FDA Approval Isn't Enough

Sometimes it takes more than one indication to really shine.

Results 11 - 20 of 4004 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for PFE


Advertisement